1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : PHARMACEUTICALS
  4. GLENMARK PHARMACEUTICALS LTD.
Glenmark Pharmaceuticals Ltd.
NSE: GLENMARK | BSE: 532296
Strong Performer, Getting Expensive
In 2 Starfolio Baskets
Download real time
Ask MarketMind AI
2317.90 -15.00 (-0.64%)
29.30% Gain from 52W Low
243.7K
NSE+BSE Volume

NSE 21 Aug, 2026 3:31 PM (IST)

Watchlist

Portfolio

Alert
US FDA Approval
Glenmark Pharma gets US FDA nod for nasal allergy spray, targeting a ~$295 million US market See details

Glenmark Pharma - GLENMARK - stock price prediction, stock forecast, target price, analyst ratings from 12 analysts

Glenmark Pharma has a share price target of Rs 2498, revenue growth forecast of -1.1%, and profit growth estimate of 69.7% for FY27, based on top 12 analyst calls.

Forecaster Screeners